Combination chemotherapy regimens using platinum-based chemotherapy and specific-inhibitors is the treatment of choice for the management of patients with large  cell carcinoma of the<unk> . Chemotherapy may be required upon histological subtype of large  cell carcinoma of the<unk> , molecular testing (presence of genetic mutations), and staging. In most cases, the predominant treatment of choice for large  cell carcinoma of the<unk>  is neoadjuvant chemotherapy or adjuvant chemotherapy, followed or preceded by surgical resection. There is no consensus on treatment in patients with large cell<unk>  neuroendocrine carcinoma. Commonly used chemotherapeutic agents, include: cisplatin, erlotinib, paclitaxel, docetaxel, carboplatin, etoposide or vinorelbine.
Large cell carcinoma of the lung medical therapy
Squamous cell carcinoma of the lung medical therapy
Small cell carcinoma of the lung medical therapy
Large cell carcinoma of the lung radiation therapy
Squamous cell carcinoma of the lung radiation therapy
Non small cell lung cancer radiation therapy
Squamous cell carcinoma of the lung chemotherapy
Non small cell lung cancer medical therapy metastatic cancer